围手术期继续抗血栓治疗下行直接显微喉镜手术的安全性
这项回顾性研究分析了581例接受直接显微喉镜手术的患者,评估围手术期抗血栓状态对出血并发症的影响。结果显示,继续抗血栓治疗并未增加围手术期出血风险,且无血栓事件发生,提示常规直接显微喉镜手术中围手术期继续抗血栓药物可能是安全的。
要点
- 围手术期继续抗血栓药物未增加直接显微喉镜手术的围手术期出血风险。
- 有基线抗血栓治疗的患者术后出血概率更高,但继续或停用药物间无显著差异。
- 研究期间未记录到需干预或再入院的术后出血及血栓事件。
核心结论
- 常规直接显微喉镜手术中围手术期继续抗血栓药物似乎是安全的。
研究设计与样本
- 回顾性病历 review,纳入2012年9月至2017年9月单术者 practice 中接受直接显微喉镜手术的患者581例。
主要发现
- 581例中179例(31%)有基线抗血栓治疗史,其中124例围手术期继续用药。
- 用药患者年龄更大(P < .01)、以男性为主(P < .01)且合并症更多(P < .01)。
- 围手术期非出血并发症22例(4%),轻微围手术期出血4例(0.7%),轻微术后出血12/479例(2.5%)。
- 无术后出血需干预或再入院,围手术期及术后无血栓事件记录。
- 基线抗血栓状态与围手术期出血无差异(P = .81);有基线抗血栓治疗者术后出血更可能(P < .01),但继续与停止用药者术后出血无显著差异(P = .45)。
临床怎么用
- 对于接受常规直接显微喉镜手术的患者,可考虑围手术期继续抗血栓药物,但需结合患者个体情况评估。
局限性
- 回顾性 chart review,证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To evaluate whether antithrombotic status impacts the incidence of perioperative or postoperative bleeding in direct microlaryngoscopy (DML). STUDY DESIGN: Retrospective chart review. METHODS: Patients undergoing DML in a single surgeon's practice from September 2012 to September 2017 were studied. Included patients underwent DML with or without biopsy, balloon dilation, microsurgery, laser ablation, or vocal fold injection. Patients were stratified based on perioperative antithrombotic status and assessed for rates of peri- and postoperative bleeding and other complications. RESULTS: Of the 581 patients meeting inclusion criteria, 179 patients (31%) had a history of baseline antithrombotic therapy. Of these patients, 124 had perioperative continuation of their therapy. Medicated patients were older (P < .01), predominately male (P < .01), and increasingly comorbid (P < .01). Perioperative complications unrelated to bleeding occurred in 22 patients (4%), minor perioperative bleeding occurred in four patients (0.7%), and minor postoperative bleeding occurred in 12 of the 479 patients with recorded follow-up (2.5%). There were no postoperative bleeds requiring intervention or readmission, and no recorded thrombotic events during the peri- and postoperative period. There was no difference in perioperative bleeding based on baseline antithrombotic status (P = .81). Patients on baseline antithrombotic therapy were more likely to have a postoperative bleed in comparison to patients without history of antithrombotic use (P < .01). However, there were no significant differences in postoperative bleeding between patients on baseline anticoagulation who continued or ceased their medication perioperatively (P = .45). CONCLUSIONS: Perioperative continuation of antithrombotic medications appears to be safe when performing routine DML. LEVEL OF EVIDENCE: 4 Laryngoscope, 2020.
引用
- Saba ES, Higgins MK, Heyes R, et al. Is Continued Perioperative Antithrombotic Therapy Safe When Performing Direct Microlaryngoscopy? Laryngoscope. 2020. PMID: 32134121. doi:10.1002/lary.28600
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。